STERIS plc (Ireland) — Earnings Quality Grade F
STE · Healthcare
Major red flags
Screening Summary
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 70 days, change -2 days YoY
AR growth 3.5% vs revenue growth 6.2%
Revenue 6.2%, CFFO 18.0%. Cash follows revenue
Expense Quality
Inventory -13.8% vs COGS 4.7%. Normal
CapEx growth 2.7% vs revenue 6.2%. Normal
SG&A/Gross Profit = 55.5%. Normal
Gross margin 44.0%, change +0.8pp. Stable
Cash Flow Quality
CFFO/NI = 1.87. Profits backed by cash
FCF $0.8B, FCF/NI = 1.27
Accruals ratio = -5.3%. Low accruals
Cash $0.2B covers only 8% of debt $2.2B
Balance Sheet Health
Goodwill+Intangibles $6.0B = 90% of equity. Over 50%
Debt/EBITDA = 1.6x. Healthy
Other assets grew 25.4% vs revenue 6.2%
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change -4% YoY. Normal
Manipulation Score
M-Score = -2.62 (< -2.22). Unlikely manipulator
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-09